VAERS 1653329
SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U6521AA
- Staat
- NM
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 29.08.2021
- Impfdatum
- 29.07.2021
- Beginn
- 29.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Symptomtext
A patient received an expired vaccine, no AE; Initial information regarding an unsolicited valid non-serious case was received from consumer/non-healthcare professional via Global Medical Information (GMI) (Reference number- 00710335) and transmitted to Sanofi on 04-Aug-2021. This case involves a 11-year-old female patient received an expired MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (expired product administered). The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (TDAP) and HPV VACCINE for prophylactic vaccination. On 29-Jul-2021, the patient received a dose of expired suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot U6521AA and expiry date: 26-Jan-2021) via an unknown route in the right deltoid for prophylactic vaccination (expired product administered). It was reported that "It was realized afterwards that the Menactra dose had expired on 26-Jan-2021. The pharmacist had incorrectly entered the expiry in the facility's electronic system as 21-Jan-2026, and that is why their system did not alert that the product should not have been used. The nurse stated that despite the pharmacist's error, the nurse who administered Menactra should have checked the label at the time, but that was not done and therefore the fact that the product was expired was overlooked prior to administration." This was a case of actual medication error due to Expired vaccine used (latency same day). At time of reporting, no adverse events were reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out by the regulatory authority. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- TDAP; HPV VACCINE
- Allergien
- -
- Vorherige Impfungen
- -